Skip to content

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Dr. Sarah Tecklenborg

Interim CEO Cystic Fibrosis Ireland

Dr Sarah Tecklenborg

Interim CEO
Cystic Fibrosis Ireland

Dr Sarah Tecklenborg was appointed Interim CEO in February 2024. Sarah joined CFI in December 2019 as Senior Research and Policy Coordinator, bringing extensive research and management experience with her. Since then, Sarah established Public and Patient Involvement (PPI) programmes, support groups such as the Pregnancy Support and Advocacy Group, and has been instrumental in campaigning for better CF care and access to medications.

Prior to CFI, Sarah worked in the HSE Sexual Health and Crisis Pregnancy Programme and the Health Research Board. Dr Tecklenborg graduated from Trinity College Dublin with a BA in Microbiology, a MSc in Global Health and a PhD in Molecular Epidemiology. Following this she undertook three post-doctoral research positions in the Royal College of Surgeons in the areas of Epidemiology, Sexual Health and Pharmacoeconomics.

Link to Irish Government websiteLink to Pobal websiteLink to Health Research Board website